Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innovex International (INVX) Other Operating Expenses (2016 - 2025)

Innovex International's Other Operating Expenses history spans 17 years, with the latest figure at $50.2 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 29933.53% year-over-year to $50.2 million; the TTM value through Dec 2025 reached $91.3 million, up 13867.13%, while the annual FY2025 figure was $91.3 million, 13867.13% up from the prior year.
  • Other Operating Expenses reached $50.2 million in Q4 2025 per INVX's latest filing, up from $40.9 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $50.2 million in Q4 2025 to a low of -$19.2 million in Q4 2022.
  • Average Other Operating Expenses over 5 years is $5.1 million, with a median of $181500.0 recorded in 2024.
  • The largest YoY upside for Other Operating Expenses was 138361.54% in 2022 against a maximum downside of 3321.98% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $596000.0 in 2021, then tumbled by 3321.98% to -$19.2 million in 2022, then skyrocketed by 100.52% to $100000.0 in 2023, then skyrocketed by 67.0% to $167000.0 in 2024, then surged by 29933.53% to $50.2 million in 2025.
  • Per Business Quant, the three most recent readings for INVX's Other Operating Expenses are $50.2 million (Q4 2025), $40.9 million (Q3 2025), and $419000.0 (Q2 2025).